Ubiquitin conjugation by the N-end rule pathway and mRNAs for its components increase in muscles of diabetic rats

Journal of Clinical Investigation

Volumn 104, Issue 10, 1999, Pages 1411-1420

  Lecker, Stewart H ^a,b   Solomon, Vered ^a   Price, S Russ ^c   Kwon, Yong Tae ^d   Mitch, William E ^c   Goldberg, Alfred L ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CALIFORNIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MUSCLE PROTEIN; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONJUGATION; CONTROLLED STUDY; IMMUNOBLOTTING; INSULIN DEFICIENCY; MUSCLE ATROPHY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RAT; SKELETAL MUSCLE; STREPTOZOCIN DIABETES;

EID: 0032751546     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI7300     Document Type: Article

References (62)

1. Nair, K.S., Ford, G.C., Ekberg, K., Fernqvist-Forbes, E., and Wahren, J. 1995. Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J. Clin. Invest. 95:2926-2937.
2. Kettelhut, I.C., Wing, S.S., and Goldberg, A.L. 1988. Endocrine regulation of protein breakdown in skeletal muscle. Diabetes Metab. Rev. 4:751-772.
3. Nair, K.S., and Schwenk, W.F. 1994. Factors controlling muscle protein synthesis and degradation. Curr. Opin. Neurol. 7:471-474.
4. Pepato, M.T., Mighorini, R.H., Goldberg, A.L., and Kettelhut, I.C. 1996. Role of different proteolytic pathways in degradation of muscle protein from streptozotocin-diabetic rats. Am J. Physiol. 271:E340-E347.
5. Price, S.R., et al. 1996. Muscle wasting in insulinopenic rats results from activation of the ATP-dependent, ubiquitin-ptoteasome proteolytic pathway by a mechanism including gene transcription. J. Clin. Invest. 98:1703-1708.
6. Solomon, V., Lecker, S.H., and Goldberg, A.L. 1998. The N-end rule pathway catalyzes a major fraction of the protein degradation in skeletal muscle. J. Biol. Chem. 273:25216-25222.
7. Rock, K.L., et al. 1994. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class 1 molecules. Cell. 78:761-771.
8. Wing, S.S., and Goldberg, A.L. 1993. Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am. J. Physiol. 264:E668-E676.
9. Coux, O., Tanaka, K., and Goldberg, A.L. 1996. Structure and functions of the 20S and 26S proteasomes. Annu. Rev. Biochem. 65:801-847.
10. Hershko, A., and Ciechanover, A. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425-479.
11. Handley, P.M., Mueckler, M., Siegel, N.R., Ciechanover, A., and Schwartz, A.L. 1991. Molecular cloning, sequence, and tissue distribution of the human ubiquitin-activating enzyme E1. Proc. Natl. Acad. Sci. USA. 88:258-262.
12. Huibregtse, J.M., Scheffner, M., Beaudenon, S., and Howley, P.M. 1995. A family of proteins structurally and functionally related to the E6-AP ubiquitin protein ligase. Proc. Natl. Acad. Sci. USA. 92:2563-2567.
13. Patton, E.E., Willems, A.R., and Tyers, M. 1998. Combinatorial control in ubiquitin-dependent proteolysis: don't Skp the F-box hypothesis. Trends Genet. 14:236-243.
14. Varshavsky, A. 1996. The N-end rule: functions, mysteries, uses. Proc. Natl. Acad. Sci. USA. 93:12142-12149.
15. 2-terminal residue of proteins to ubiquitin-protein ligase. Use of amino acid derivatives to characterize specific binding sites. J. Biol. Chem. 263:2693-2698.
16. Mitch, W.E., and Goldberg, A.L. 1996. Mechanisms of muscle wasting. The role of the ubiquitin-proteasome pathway. N. Engl. J. Med. 335:1897-1905.
17. Lecker, S.H., Solomon, V., Mitch, W.E., and Goldberg, A.L. 1999. Muscle protein breakdown and the critical role of the ubiquitin-proteasome pathway in normal and disease states. J. Nutr. 129:227S-237S.
18. Bailey, J.L., et al. 1996. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J. Clin. Invest. 97:1447-1453.
19. Tawa, N.E., Odessey, R., and Goldberg, A.L. 1997. Inhibitors of the proteasome reduce the accelerated proteolysis in atrophying rat skeletal muscles. J. Clin. Invest. 100:197-203.
20. Hobler, S.C., Tiao, G., Fischer, J.E., Monaco, J., and Hasselgren, P.O. 1998. Sepsis-induced increase in muscle proteolysis is blocked by specific proteasome inhibitors. Am. J. Physiol. 274:R30-R37.
21. Temparis, S., et al. 1994. Increased ATP-ubiquitin-dependent proteolysis in skeletal muscles of tumor-bearing rats. Cancer Res. 54:5568-5573.
22. Tiao, G., et al. 1994. Sepsis stimulates nonlysosomal, energy-dependent proteolysis and increases ubiquitin mRNA levels in rat skeletal muscle. J. Clin. Invest. 94:2255-2264.
23. Mitch, W.E., et al. 1994. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J. Clin. Invest. 93:2127-2133.
24. Medina, R., Wing, S.S., and Goldberg, A.L. 1995. Increase in levels of polyubiquitin and proteasome mRNA in skeletal muscle during starvation and denervation atrophy. Biochem. J. 307:631-637.
25. Fang, C.H., et al. 1995. Burn injury stimulates multiple proteolytic pathways in skeletal muscle, including the ubiquitin-energy-dependent pathway. J. Am. College Surgeons. 180:161-170.
26. Wing, S.S., and Banville, D. 1994. 14-kDa ubiquitin-conjugating enzyme: structure of the rat gene and regulation upon fasting and by insulin. Am. J. Physiol. 267:E39-E48.
27. Dardevet, D., et al. 1995. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging. J. Clin. Invest. 96:2113-2119.
28. 2+-activated and ATP-ubiquitin-dependent proteinases in the unweighted rat soleus muscle. Biochem. J. 316:65-72.
29. 2+-activated, and ubiquitin-proteasome proteolytic pathways. J. Clin. Invest. 97:1610-1617.
30. Wing, S.S., Haas, A.L., and Goldberg, A.L. 1995. Increase in ubiquitin-protein conjugates concomitant with the increase in proteolysis in rat skeletal muscle during starvation and atrophy denervation. Biochem. J. 307:639-645.
31. Tiao, G., et al. 1996. Energy-ubiquitin-dependent muscle proteolysis during sepsis in rats is regulated by glucocorticoids. J. Clin. Invest. 97:339-348.
32. Baracos, V.E., DeVivo, C., Hoyle, D.H., and Goldberg, A.L. 1995. Activation of the ATP-ubiquitin-proreasome pathway in skeletal muscle of cachectic rats bearing a hepatoma. Am. J. Physiol. 268:E996-B1006.
33. Llovera, M., et al. 1994. Ubiquitin gene expression is increased in skeletal muscle of tumour-bearing rats. FEBS Lett. 338:311-318.
34. Solomon, V., Baracos, V., Sarraf, P., and Goldberg, A.L. 1998. Rates of ubiquitin conjugation increase when muscles atrophy, largely through activation of the N-end rule pathway. Proc. Natl. Acad. Sci. USA. 95:12602-12607.
35. Solomon, V., and Goldberg, A.L. 1996. Importance of the ATP-ubiquitin-proteasome pathway in the degradation of soluble and myofibrillar proteins in rabbit muscle extracts. J. Biol. Chem. 271:26690-26697.
36. Mitch, W.E., et al. 1999. Evaluation of signals activating the ubiquitin-proteasome proteolysis in a model of muscle wasting. Am. J. Physiol. 276:C1132-C1138.
37. Johnston, N.L., and Cohen, R.E. 1991. Uncoupling ubiquitin-protein conjugation from ubiquitin-dependent proteolysis by use of beta, gamma-non-hydrolyzable ATP analogues. Biochemistry. 30:7514-7522.
38. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:680-685.
39. Kwon, Y.T., et al. 1998. The mouse and human genes encoding the recognition component of the N-end rule pathway. Proc. Natl. Acad. Sci. USA. 95:7898-7903.
40. Harlow, E., and Lane, D. 1988. Antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, NY.
41. Joyner, A.L., Kornberg, T., Coleman, K.G., Cox, D.R., and Martin, G.R. 1985. Expression during embryogenesis of a mouse gene with sequence homology to the Drosophila engrailed gene. Cell. 43:29-37.
42. Church, G.M., and Gilbert, W. 1984. Genomic sequencing. Proc. Natl. Acad. Sci. USA. 81:1991-1995.
43. 14k) is homologous to the yeast DNA repair gene RAD6. J. Biol. Chem. 267:6495-6501.
44. Fagan, J.M., Waxman, L., and Goldberg, A.L. 1987. Skeletal muscle and liver contain a soluble ATP + ubiquitin-dependent proteolyric system. Biochem. J. 243:335-343.
45. Ciechanover, A., Elias, S., Heller, H., and Hershko, A. 1982. "Covalent affinity" purification of ubiquitin-activating enzyme. J. Biol. Chem. 257:2537-2542.
46. 2-terminal binding sites on a single enzyme. J. Biol. Chem. 265:3685-3690.
47. Sung, P., Prakash, S., and Prakash, L. 1991. Stable ester conjugate between the S. cerevisiae RAD6 protein and ubiquitin has no biological activity. J. Mol. Biol. 221:745-749.
48. Townsley, F.M., Aristarkhov, A., Beck, S., Hershko, A., and Ruderman, J.V. 1997. Dominant-negative cyclin-selective ubiquitin carrier protein E2-C/UbcH10 blocks cells in metaphase. Proc. Natl. Acad. Sci. USA. 94:2362-2367.
49. Aristarkhov, A., et al. 1996. E2-C, a cyclin-selective ubiquitin carrier protein required for the destruction of mitotic cyclins. Proc. Natl. Acad. Sci. USA. 93:4294-4299.
50. Haas, A.L., and Bright, P.M. 1988. The resolution and characterization of putative ubiquitin carrier protein isozymes from rabbit reticulocytes. J. Biol. Chem. 263:13258-13267.
51. Brown, J.L., and Roberts, W.K. 1976. Evidence that approximately eighty percent of the soluble proteins from Ehrlich ascites cells are N-alpha acetylated. J. Biol. Chem. 251:1009-1014.
52. Bartel, B., Wunning, I., and Varshavsky, A. 1990. The recognition component of the N-end rule pathway. EMBO J. 9:3179-3189.
53. Madura, K., and Varshavsky, A. 1994. Degradation of G alpha by the N-end rule pathway. Science. 265:1454-1458.
54. Byrd, C., Turner, G.C., and Varshavsky, A. 1998. The N-end rule pathway controls the import of peptides through degradation of a transcriptional repressor. EMBO J. 17:269-277.
55. England, B.K., et al. 1995. Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. Am. J. Physiol. 268:C1395-C1400.
56. Wilkinson, K.D., et al. 1995. Metabolism of the polyubiquitin degradation signal - structure, mechanism, and role of isopeptidase T. Biochemistry. 34:14535-14546.
57. Hegde, A.N., et al. 1997. Ubiquitin C-terminal hydrolase is an immediate-early gene essential for long-term facilitation in Aplysia. Cell. 89:115-126.
58. Hershko, A., and Rose, I.A. 1987. Ubiquitin-aldehyde: a general inhibitor of ubiquitin-recycling processes. Proc. Natl. Acad. Sci. USA. 84:1829-1833.
59. Skoyra, D., et al. 1999. Reconstitution of G1 cyclin ubiquitination with complexes containing SCF-GRR1 and Rbx1. Science. 284:562-565.
60. Koegl, M., et al. 1999. A novel ubiquitination factor, E4, is involved in multi-ubiquitin chain assembly. Cell. 96:635-644.
61. 2 termini substrates of the ubiquitin pathway. J. Biol. Chem. 263:11155-11167.
62. Grigoryev, S., et al. 1996. A mouse amidase specific for N-terminal asparagine. The gene, the enzyme, and their function in the N-end rule pathway. J. Biol. Chem. 271:28521-28532.